To investigate the metabolic changes induced by SLC6A14 in gemcitabine-resistant cancer cells, we analyzed metabolic enzyme levels, including those involved in the tricarboxylic acid (TCA) cycle, in the absence of SLC6A14 (Supplementary Fig. 3a, b). The gene discussed is SLC6A14; the disease is cancer.